References
- Palmer KJa Holliday SM, Brogden RN. Mefloquine: A review of its antimalarial activity, pharmacokinetic properties, and therapeutic efficacy. Drugs 1993; 45: 430–75.
- Lobel HO, Miani M, Eng T, Bernard KW, Hightower AW, Campbell CC. Long-term malaria prophylaxis with weekly mefloquine. Lancet 1993; 341: 848–51
- Steffen R, Fuchs E, Schildknecht J, et al. Mefloquine compared with other malaria chemo-prophylactic regimens in tourists visiting East Africa. Lancet 1993; 341: 1299–1303.
- Nosten F, Luxemburger C, ter Kuile FO, et al. Treatment of multidrug-resistant P. falciparum malaria with 3-day artesunate mefloquine combination. J Infect Dis 1994; 170: 971–7.
- Price RN, Nosten F, Luxemburger C, et al. Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria. Trans R Soc Trop Med Hyg 1995; 89: 523–7.
- ter Kuile FO, Luxemburger C, Nosten F, et al. Mefloquine treatment of acute falciparum malaria; a prospective study of non-serious adverse effects in 3673 patients. Bull WHO (in press).
- Weinke T, Trautmann M, Held T, et al. Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg 1991; 45: 86–91.
- Luxemburger C, Nosten F, ter Kuile F, Frejacques L, Chongsuphajaisiddhi T, White NJ. Mefloquine for multidrug-resistant malaria. Lancet 1991; 338:1268.
- Phillips-Howard PA, ter Kuile FO. CNS adverse events associated with antimalarial agents. Fact or fiction? Drug Safety 1995; 12: 370–83.
- Slutsker LM, Khoromana CO, Payne D, et al. Mefloquine therapy for Plasmodium falciparum malaria in children under 5 years of age in Malawi: in vivo/in vitro efficacy and correlation of drug concentration with parasitological outcome. Bull WHO 1990; 68: 53–9.
- Sowunmi A, Salako LA, Walker O, Ogundahunsi AT. Clinical efficacy of mefloquine in children suffering from chloroquine-resistant Plasmodium falciparum malaria in Nigeria. Trans R Soc Trop Med Hyg 1990; 84: 761–4.
- Sowunmi A, Oduola AMJ. Open comparison of mefloquine, mefloquine-sulfadoxine-pyrimethamine and chloroquine in acute uncomplicated falciparum malaria in children. Trans R Soc Trop Med Hyg 1995; 89: 303–5.
- Luxemburger C, Kyaw Lay Thwai, White NJ, et al. The epidemiology of malaria in a Karen population on the Thai-Burmese border. Trans R Soc Trop Med Hyg 1996; 90: 105–11.
- ter Kuile FO, Nosten F, Thieren M, et al. High dose mefloquine in the treatment of multi-drug resistant falciparum malaria. J Infect Dis 1992; 166: 1393–9.
- ter Kuile FO, Dolan G, Nosten F, et al. Halo-fantrine versus mefloquine in the treatment of multi-drug resistant falciparum malaria. Lancet 1993; 341: 1044–9.
- Luxemburger C, ter Kuile FO, Nosten F, et al. Single day mefloquine-artesunate combination in the treatment of multidrug resistant falciparum malaria. Trans R Soc Trop Med Hyg 1994; 88: 213–17.
- World Health Organization. Severe and complicated malaria. Trans R Soc Trop Med Hyg 1990; 84(suppl. 2): 1–65.
- ter Kuile FO, Luxemburger C, Nosten F, et al. Predictors of mefloquine treatment failure; a prospective study of 1590 patients with uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg 1995; 89:660–4.